McKinsey Settles For $45 Million After Boosting Opioid Sales In Nevada

Spread the love

The consulting firm advised Purdue Pharma to “turbocharge” their Oxycontin sales by issuing more prescription doses, killing thousands in Nevada.
Source: The Federlist

 76 total views,  1 views today